Background: SINE-VNTR-Alu retrotransposons represent one class of transposable elements which contribute to the regulation and evolution of the primate genome and have the potential to be involved in genetic instability and disease progression. However, these polymorphic elements have not been extensively analysed when addressing the missing heritability of neurodegenerative diseases, including Parkinson´s disease (PD) and amyotrophic lateral sclerosis (ALS). SVA_67, a retrotransposon insertion polymorphism, is located in a 1.8 Mb region of high linkage disequilibrium, called the MAPT locus, which is known to contribute to increased risk of developing PD, frontotemporal dementia and other tauopathies. This study was conducted to investigate the role of SVA_67 in directing differential gene expression at this locus by characterising the impact of SVA_67 allele dosage on isoform expression of several genes in the MAPT locus.Methods:In this study, transcriptomic data from both the Parkinson’s Progression Markers Initiative and New York Genome Center Consortium Target ALS cohort were used. The Parkinson’s data was from gene expression in the blood and the ALS data from a variety of central nervous system (CNS) regions. The association of three different genotypes (AA, PA, PP) based on the presence (P) or absence (A) of SVA_67 was analysed. The unpaired Wilcoxon test was used to compare two independent groups of samples and to demonstrate statistical significance.Results: Using two different datasets for analysis, we could demonstrate that SVA_67 presence or absence was significantly associated with 1) changes in expression of multiple genes at this locus and 2) both differential isoform and tissue specific expression of these genes.Conclusions:This study highlights the importance of addressing SVA polymorphism in disease genetics to gain insight into a better understanding of the role of these regulatory domains to a variety of neurodegenerative diseases. Therefore, this study underlines an additional type of variation to be considered at the MAPT locus and an added layer of complexity when analysing the missing heritability of neurodegenerative diseases.